Clinical Trials Directory

Trials / Completed

CompletedNCT02189018

Activity To Improve Outcomes in Peripheral Arterial Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
208 (actual)
Sponsor
Baltimore VA Medical Center · Federal
Sex
All
Age
21 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Peripheral artery disease (PAD) results in blockages of arteries (blood vessels) in the legs and decreased blood flow to the legs. This may cause difficulty or pain with walking or other activities that use leg muscles. Exercise may help improve blood flow in the legs and improve the ability to walk. This research project is being implemented in adults with PAD to examine the effects of exercise or weight loss programs on lower extremity blood flow, health, and physical function.

Detailed description

This pilot study seeks to gather data on different exercise interventions in PAD. Collectively, the proposed studies will gather data on the role of novel exercise interventions in those with PAD who are receiving conservative treatment as well as those who have undergone an endovascular intervention for lower extremity arterial disease. We hypothesize that patients who undergo an exercise intervention will: A) show improved lower extremity perfusion and B) improve their functional ability, compared to a standard care control group over 6 months of follow-up. We further hypothesize that these improvements are mediated through angiogenesis and increased perfusion of the lower limb, as well as improvements in muscle strength, mass, and function.

Conditions

Interventions

TypeNameDescription
OTHERActive ExerciseActive exercise on a treadmill
OTHERNeuromuscular electrical stimulationNeuromuscular electrical stimulation
OTHERWeight loss and active exerciseWeight loss and active exercise on a treadmill
OTHERAd lib activity at homeAd lib activity at home

Timeline

Start date
2014-08-01
Primary completion
2023-07-04
Completion
2023-07-04
First posted
2014-07-14
Last updated
2023-07-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02189018. Inclusion in this directory is not an endorsement.